ESR1 and breast carcinoma: Breast cancer 5-year survival has significantly increased, due to early detection and the introduction of therapies, such as specific estrogen receptor modulators, aromatase inhibitors, specific chemotherapeutic agents and more comprehensive recent precision medicine strategies.